HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

ADAMTS-5 Inhibitor GLPG1972

Also Known As:

ADAMTS-5 Inhibitor S201086

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 207
- 1-Ring Heterocyclic Compounds
  - Azoles: 2199
    - Imidazoles: 152
      - Imidazolidines: 40
        ADAMTS-5 Inhibitor GLPG1972: 3
  - Piperazines: 26
    - ADAMTS-5 Inhibitor GLPG1972: 3

Experts

1.	Deckx, Henri: 2 articles (01/2022 - 12/2021)
2.	van der Aar, Ellen: 2 articles (01/2022 - 12/2021)
3.	Bernard, K: 1 article (07/2023)
4.	Bliddal, H: 1 article (07/2023)
5.	Chimits, D: 1 article (07/2023)
6.	Conaghan, P G: 1 article (07/2023)
7.	Deckx, H: 1 article (07/2023)
8.	Eckstein, F: 1 article (07/2023)
9.	Grankov, S: 1 article (07/2023)
10.	Hatch, S: 1 article (07/2023)

Related Diseases

1.

Knee Osteoarthritis

12/01/2021 - "The design of a randomized, placebo-controlled, dose-ranging trial to investigate the efficacy and safety of the ADAMTS-5 inhibitor S201086/GLPG1972 in knee osteoarthritis."
07/01/2023 - "To evaluate the efficacy and safety of the anti-catabolic ADAMTS-5 inhibitor S201086/GLPG1972 for the treatment of symptomatic knee osteoarthritis. "
01/01/2022 - "Safety, Pharmacokinetics, and Pharmacodynamics of the ADAMTS-5 Inhibitor GLPG1972/S201086 in Healthy Volunteers and Participants With Osteoarthritis of the Knee or Hip."

Related Drugs and Biologics

1.	ADAMTS5 inhibitor GLPG1972